Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Prevalence of low LDL-cholesterol levels and elevated high-sensitivity C-reactive protein levels in apparently healthy Korean adults.

Sung KC, Rhee EJ, Kim H, Park JB, Kim YK, Rosenson RS.

Nutr Metab Cardiovasc Dis. 2012 Dec;22(12):1061-6. doi: 10.1016/j.numecd.2011.03.006. Epub 2011 Jul 23.

PMID:
21782402
2.

Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).

Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group.

Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):616-23. doi: 10.1161/CIRCOUTCOMES.109.848473. Epub 2009 Sep 22.

3.
6.
7.

Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.

Ridker PM, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Khurmi NS, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Trial Study Group.

Am J Cardiol. 2007 Dec 1;100(11):1659-64. Epub 2007 Oct 24.

8.
9.

One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.

Ferdinand KC, Davidson MH, Kelly MT, Setze CM.

Am J Cardiovasc Drugs. 2012 Apr 1;12(2):117-25. doi: 10.2165/11597940-000000000-00000.

PMID:
22263674
12.
13.

Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study.

Glynn RJ, MacFadyen JG, Ridker PM.

Clin Chem. 2009 Feb;55(2):305-12. doi: 10.1373/clinchem.2008.120642. Epub 2008 Dec 18.

14.

Jupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?

Shishehbor MH, Hazen SL.

Cleve Clin J Med. 2009 Jan;76(1):37-44. doi: 10.3949/ccjm.75a.08105.

15.
16.

Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.

Stewart RA.

Future Cardiol. 2009 May;5(3):231-6. doi: 10.2217/fca.09.8.

PMID:
19656039
18.

Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis.

Liu B, Zhang JY, Cao HM, Wang Q, Wang HB.

Intern Med. 2012;51(10):1177-82. Epub 2012 May 15.

20.

The JUPITER trial: How will it change clinical practice?

Watson KE.

Rev Cardiovasc Med. 2009 Spring;10(2):91-6. Review.

PMID:
19593321

Supplemental Content

Support Center